coronary atherosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who participated in our department from May 2020 to November 2021 to explore the effects of ioxanol on short-term renal function in patients after PCI (ChiCTR2200064328); 2. Patients who underwent intra-coronary OCT examination during ChiCTR2200064328 to explore the effect of ioxanol on short-term renal function after PCI; 3. Patients willing to review coronary angiography and OCT on time; 4. Willing to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Women during pregnancy, lactation and without effective contraceptive measures; 2. Have a history of mental illness that is not currently under control; 3. Uncured hyperthyroidism; 4. Infections or diseases of the immune system; 5. Contrast agent allergy; 6. There are any other factors in the study that are not compatible with the study for any reason or that the investigator considers unsuitable for inclusion in the study; 7. Refusing to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intra coronary disease;Inflammatory factors; | — |
Countries
china
Contacts
The Second Affiliated Hospital of Army Medical University